SPI-001, identified by its CAS number 1220996-46-2, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may vary, compounds like SPI-001 typically exhibit unique structural and functional properties that make them suitable for various applications, particularly in drug development. Such substances often possess specific functional groups that contribute to their biological activity, solubility, and stability. The molecular weight, melting point, and solubility in different solvents are also critical characteristics that influence their behavior in biological systems. Additionally, SPI-001 may interact with specific biological targets, which can be assessed through various pharmacological studies. Understanding its mechanism of action, toxicity profile, and potential therapeutic applications is essential for evaluating its utility in clinical settings. As research progresses, more detailed information regarding its characteristics and applications may become available, contributing to the broader understanding of its role in pharmaceutical science.

SPI-001

1220996-46-2: SPI-001, identified by its CAS number 1220996-46-2, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may vary, compounds like SPI-001 typically exhibit unique structural and functional properties that make them suitable for various applications, particularly in drug development. Such substances often possess specific functional groups that contribute to their biological activity, solubility, and stability. The molecular weight, melting point, and solubility in different solvents are also critical characteristics that influence their behavior in biological systems. Additionally, SPI-001 may interact with specific biological targets, which can be assessed through various pharmacological studies. Understanding its mechanism of action, toxicity profile, and potential therapeutic applications is essential for evaluating its utility in clinical settings. As research progresses, more detailed information regarding its characteristics and applications may become available, contributing to the broader understanding of its role in pharmaceutical science.

SPI-001 is a selective inhibitor of PPM1D (IC50=0.48 µM) that exhibits anticancer activity. The compound inhibits the phosphatase activity of PPM1D in human breast cancer cells overexpressing PPM1D and enhances the phosphorylation of p53. Additionally, SPI-001 suppresses cell proliferation by inducing apoptosis.

CAS 1220996-46-2

SPI-001

SPI-001

Ref: TM-T89868